Yang M, Chen J, Cao W, Ding L, Ng KK, Jin H, Zhang Z & Zheng G Nanomedicine, 2011 Research in the development of nanoscale drug carriers primarily focuses on maximizing drug delivery efficiency to tumor tissues. However, less attention has been given to minimizing drug toxicity to non-targeted cellsContinue Reading
Liu TW, Akens MK, Chen J, Wise-Milestone L, Wilson BC & Zheng G Bioconjugate Chemistry, 2011 Breast cancer is the second leading cause of cancer-related death in women. Approximately 85% of patients with advanced cases will develop spinal metastases. The vertebral column is the most common site of breast cancerContinue Reading
Ng KK, Lovell JF & Zheng G Accounts of Chemical Research, 2011 Over hundreds of millions of years, animals have evolved endogenous lipoprotein nanoparticles for shuttling hydrophobic molecules to different parts of the body. In the last 70 years, scientists have developed an understanding of lipoprotein function, often in relationshipContinue Reading
Marotta DE, Cao W, Wileyto EP, Li H, Corbin I, Rickter E, Glickson JD, Chance B, Zheng G & Busch TM Nanomedicine, 2011 Aim: To evaluate the novel nanoparticle reconstituted bacteriochlorin e6 bisoleate low-density lipoprotein (r-Bchl-BOA-LDL) for its efficacy as a photodynamic therapy agent delivery system in xenografts of humanContinue Reading
Lovell JF, Jin CS, Huynh E, Jin H, Kim C, Rubinstein JL, Chan WCW, Cao W, Wang LV & Zheng G Nature Materials, 2011 (Download author version here) Optically active nanomaterials promise to advance a range of biophotonic techniques through nanoscale optical effects and integration of multiple imaging and therapeuticContinue Reading
Jin H, Lovell JF, Chen J, Ng KK, Ding L, Zhang Z & Zheng G Photochemical and Photobiological Sciences, 2011 Following cellular delivery, most drugs must escape endosomes and lysosomes and reach the cytosol to be effective. This is particularly significant for nanoparticles, which can carry a large drug payload,Continue Reading
Yang M, Jin H, Chen J, Ding L, Ng KK, Lin Q, Lovell JF, Zhang Z & Zheng G Small, 2011 High-density lipoprotein (HDL)-mimicking peptide–phospholipid scaffold (HPPS) nanoparticles are used as a flexible and biocompatible nanocarrier for the delivery of small interfering RNA (siRNA). The direct cytosolic delivery ability ofContinue Reading
Shi J, Liu TW, Chen J, Green D, Jaffray D, Wilson BC, Wang F & Zheng G Theranostics, 2011 Porphyrin based photosensitizers are useful agents for photodynamic therapy (PDT) and fluorescence imaging of cancer. Porphyrins are also excellent metal chelators forming highly stable metallo-complexes making them efficient delivery vehicles forContinue Reading
Liu TW, Chen J, Burgess L, Cao W, Shi J, Wilson BC & Zheng G Theranostics, 2011 The complimentary ability of different noninvasive imaging technologies with therapeutic modalities can be used in tandem providing high-resolution and highly sensitive imaging of events at the molecular and cellular level providing a meansContinue Reading
Jin H, Lovell JF, Chen J, Ng KK, Cao W, Ding L, Zhang Z & Zheng G Cancer Nanotechology, 2010 Targeted nanoparticles have the potential to deliver a large drug payload specifically to cancer cells. Targeting requires that a ligand on the nanoparticle surface interact with a specific membrane receptorContinue Reading
